[S02DA03, antipyrine, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Antipyrine.]
[B01AD01, streptokinase, Streptokinase may increase the hypotensive activities of Tadalafil.]
[J01GA01, streptomycin, Tadalafil may decrease the excretion rate of Streptomycin which could result in a higher serum level.]
[A02BX02, sucralfate, Sucralfate may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[J01CG01, sulbactam, Tadalafil may decrease the excretion rate of Sulbactam which could result in a higher serum level.]
[J01EC02, sulfadiazine, Sulfadiazine may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[J01EC01, sulfamethoxazole, Tadalafil may decrease the excretion rate of Sulfamethoxazole which could result in a higher serum level.]
[M01AB02, sulindac, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Sulindac.]
[M01AX04, apazone, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Azapropazone.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Tadalafil.]
[N05CD07, temazepam, Temazepam may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[L01CB02, teniposide, The metabolism of Teniposide can be decreased when combined with Tadalafil.]
[R03CC03, terbutaline, Terbutaline may decrease the antihypertensive activities of Tadalafil.]
[B01AE07, dabigatran etexilate, Tadalafil may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.]
[G03BA03, testosterone, Testosterone may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[S03AA02, tetracycline, Tetracycline may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[J01DI02, ceftaroline fosamil, Ceftaroline fosamil may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[N05AE05, lurasidone, Lurasidone may decrease the antihypertensive activities of Tadalafil.]
[N04BC07, apomorphine, The metabolism of Tadalafil can be decreased when combined with Apomorphine.]
[L04AX02, thalidomide, The metabolism of Tadalafil can be increased when combined with Thalidomide.]
[R03DA07, theobromine, Theobromine may increase the excretion rate of Tadalafil which could result in a lower serum level and potentially a reduction in efficacy.]
[P02CA02, thiabendazole, Thiabendazole may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[R06AD03, thiethylperazine, Thiethylperazine may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[N05CA19, thiopental, Thiopental may increase the hypotensive activities of Tadalafil.]
[N05AB08, thioproperazine, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Thioproperazine.]
[N05AC02, thioridazine, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Thioridazine.]
[G04BE06, moxisylyte, Moxisylyte may decrease the antihypertensive activities of Tadalafil.]
[N05AL03, tiapride, Tadalafil may decrease the excretion rate of Tiapride which could result in a higher serum level.]
[B01AC05, ticlopidine, Ticlopidine may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[S01ED01, timolol, Timolol may increase the hypotensive activities of Tadalafil.]
[P01AB02, tinidazole, Tadalafil may decrease the excretion rate of Tinidazole which could result in a higher serum level.]
[S01AA12, tobramycin, Tadalafil may decrease the excretion rate of Tobramycin which could result in a higher serum level.]
[A10BB05, tolazamide, Tadalafil may decrease the excretion rate of Tolazamide which could result in a higher serum level.]
[M02AX02, tolazoline, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Tolazoline.]
[V04CA01, tolbutamide, Tadalafil may decrease the excretion rate of Tolbutamide which could result in a higher serum level.]
[M02AA21, tolmetin, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Tolmetin.]
[N02AX02, tramadol, Tramadol may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[N06AF04, tranylcypromine, Tranylcypromine may increase the hypotensive activities of Tadalafil.]
[N06AX05, trazodone, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Trazodone.]
[L01XF01, tretinoin, The metabolism of Tadalafil can be decreased when combined with Tretinoin.]
[S01BA05, triamcinolone, The metabolism of Tadalafil can be increased when combined with Triamcinolone.]
[C03DB02, triamterene, Triamterene may increase the excretion rate of Tadalafil which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD05, triazolam, Tadalafil may decrease the excretion rate of Triazolam which could result in a higher serum level.]
[C03AA06, trichlormethiazide, The therapeutic efficacy of Tadalafil can be increased when used in combination with Trichlormethiazide.]
[A16AX12, trientine, Tadalafil may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.]
[N05AB06, trifluoperazine, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Trifluoperazine.]
[S01AD02, trifluridine, Trifluridine may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[R03BA07, mometasone, The metabolism of Tadalafil can be increased when combined with Mometasone.]
[A03AA05, trimebutine, Tadalafil may decrease the excretion rate of Trimebutine which could result in a higher serum level.]
[S01ED04, metipranolol, Tadalafil may increase the hypotensive activities of Metipranolol.]
[C02BA01, trimethaphan, Tadalafil may increase the hypotensive activities of Trimethaphan.]
[J01EA01, trimethoprim, Trimethoprim may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[N06AA06, trimipramine, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Trimipramine.]
[J01FA08, troleandomycin, The serum concentration of Tadalafil can be increased when it is combined with Troleandomycin.]
[N06AX24, vilazodone, Vilazodone may decrease the antihypertensive activities of Tadalafil.]
[C09CA09, azilsartan medoxomil, Tadalafil may increase the hypotensive activities of Azilsartan medoxomil.]
[R03DX07, roflumilast, Tadalafil may decrease the excretion rate of Roflumilast which could result in a higher serum level.]
[L01FX04, ipilimumab, Tadalafil may decrease the excretion rate of Ipilimumab which could result in a higher serum level.]
[R02AA14, oxyquinoline, Tadalafil may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.]
[A10BH05, linagliptin, The metabolism of Tadalafil can be decreased when combined with Linagliptin.]
[J05AP03, boceprevir, The serum concentration of Tadalafil can be increased when it is combined with Boceprevir.]
[J05AP02, telaprevir, The serum concentration of Tadalafil can be increased when it is combined with Telaprevir.]
[S01AA28, vancomycin, Tadalafil may decrease the excretion rate of Vancomycin which could result in a higher serum level.]
[N03AX21, ezogabine, Tadalafil may decrease the excretion rate of Ezogabine which could result in a higher serum level.]
[B01AF01, rivaroxaban, Tadalafil may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[R03AC18, indacaterol, Indacaterol may decrease the antihypertensive activities of Tadalafil.]
[B01AC24, ticagrelor, The metabolism of Ticagrelor can be decreased when combined with Tadalafil.]
[C08DA01, verapamil, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Verapamil.]
[N06AX09, viloxazine, The metabolism of Tadalafil can be decreased when combined with Viloxazine.]
[C04AX07, vincamine, Tadalafil may increase the hypotensive activities of Vincamine.]
[L01CA02, vincristine, The metabolism of Vincristine can be decreased when combined with Tadalafil.]
[B03BA01, vitamin B12, Cyanocobalamin may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[B01AA03, warfarin, Tadalafil may decrease the excretion rate of Warfarin which could result in a higher serum level.]
[N01AX15, xenon, Xenon may decrease the antihypertensive activities of Tadalafil.]
[C03BA10, xipamide, Xipamide may increase the excretion rate of Tadalafil which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AF05, zuclopenthixol, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Zuclopenthixol.]
[J05AE02, indinavir, The serum concentration of Tadalafil can be increased when it is combined with Indinavir.]
[M05BA03, pamidronic acid, Pamidronic acid may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[M05BA05, tiludronic acid, Tadalafil may decrease the excretion rate of Tiludronic acid which could result in a higher serum level.]
[B06AC02, icatibant, Tadalafil may decrease the excretion rate of Icatibant which could result in a higher serum level.]
[L01ED01, crizotinib, The metabolism of Crizotinib can be decreased when combined with Tadalafil.]
[A02BC04, rabeprazole, Tadalafil may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[N05AE04, ziprasidone, Ziprasidone may increase the antihypertensive activities of Tadalafil.]
[G03AC10, drospirenone, Drospirenone may increase the excretion rate of Tadalafil which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AC02, deferiprone, Tadalafil may decrease the excretion rate of Deferiprone which could result in a higher serum level.]
[N02BA01, aspirin, Acetylsalicylic acid may decrease the antihypertensive activities of Tadalafil.]
[L01EJ01, ruxolitinib, Tadalafil may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.]
[G04BD07, tolterodine, Tadalafil may decrease the excretion rate of Tolterodine which could result in a higher serum level.]
[J01DH04, doripenem, Tadalafil may decrease the excretion rate of Doripenem which could result in a higher serum level.]
[C07AB03, atenolol, Atenolol may increase the hypotensive activities of Tadalafil.]
[L01FA01, rituximab, Tadalafil may increase the hypotensive activities of Rituximab.]
[J02AC03, voriconazole, The serum concentration of Tadalafil can be increased when it is combined with Voriconazole.]
[S01FA01, atropine, Atropine may decrease the antihypertensive activities of Tadalafil.]
[M01CB03, auranofin, Tadalafil may decrease the excretion rate of Auranofin which could result in a higher serum level.]
[L01EK01, axitinib, The metabolism of Axitinib can be decreased when combined with Tadalafil.]
[R07AX02, ivacaftor, The metabolism of Ivacaftor can be decreased when combined with Tadalafil.]
[H02AB11, prednylidene, The metabolism of Tadalafil can be increased when combined with Prednylidene.]
[B03XA04, peginesatide, Tadalafil may decrease the excretion rate of Peginesatide which could result in a higher serum level.]
[L01BC07, azacitidine, Tadalafil may decrease the excretion rate of Azacitidine which could result in a higher serum level.]
[L04AX01, azathioprine, Tadalafil may decrease the excretion rate of Azathioprine which could result in a higher serum level.]
[L01BC05, gemcitabine, Gemcitabine may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[J01DF01, aztreonam, Aztreonam may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[R02AB04, bacitracin, Bacitracin may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Tadalafil.]
[M03BX01, baclofen, The risk or severity of adverse effects can be increased when Baclofen is combined with Tadalafil.]
[A08AA11, lorcaserin, Tadalafil may decrease the excretion rate of Lorcaserin which could result in a higher serum level.]
[G04BD12, mirabegron, Mirabegron may decrease the antihypertensive activities of Tadalafil.]
[V03AX03, cobicistat, The serum concentration of Tadalafil can be increased when it is combined with Cobicistat.]
[J05AJ02, elvitegravir, The serum concentration of Tadalafil can be increased when it is combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Tadalafil can be decreased when it is combined with Enzalutamide.]
[C01CA18, octopamine, Octopamine may decrease the antihypertensive activities of Tadalafil.]
[D02BA02, octinoxate, Tadalafil may decrease the excretion rate of Octinoxate which could result in a higher serum level.]
[J05AE04, nelfinavir, The serum concentration of Tadalafil can be increased when it is combined with Nelfinavir.]
[S01GA07, brimonidine, Brimonidine may increase the antihypertensive activities of Tadalafil.]
[N04BD02, rasagiline, Rasagiline may increase the hypotensive activities of Tadalafil.]
[C08CA13, lercanidipine, Lercanidipine may increase the hypotensive activities of Tadalafil.]
[N03AX22, perampanel, The metabolism of Perampanel can be decreased when combined with Tadalafil.]
[N02CC03, zolmitriptan, Zolmitriptan may decrease the antihypertensive activities of Tadalafil.]
[V09IX04, fluorodeoxyglucose F18, Tadalafil may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.]
[N01AA01, ethyl ether, Diethyl ether may decrease the antihypertensive activities of Tadalafil.]
[G04BE03, sildenafil, The risk or severity of adverse effects can be increased when Sildenafil is combined with Tadalafil.]
[V08CA11, gadofosveset, Tadalafil may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Tadalafil.]
[B01AF02, apixaban, The metabolism of Apixaban can be decreased when combined with Tadalafil.]
[A16AX08, teduglutide, Tadalafil may decrease the excretion rate of Teduglutide which could result in a higher serum level.]
[A10BH04, alogliptin, Tadalafil may decrease the excretion rate of Alogliptin which could result in a higher serum level.]
[A16AX09, glycerol phenylbutyrate, Tadalafil may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.]
[C03AA01, bendroflumethiazide, The therapeutic efficacy of Tadalafil can be increased when used in combination with Bendroflumethiazide.]
[L04AX06, pomalidomide, Tadalafil may decrease the excretion rate of Pomalidomide which could result in a higher serum level.]
[N02BA10, benorilate, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Benorilate.]
[A10BK02, canagliflozin, Canagliflozin may increase the excretion rate of Tadalafil which could result in a lower serum level and potentially a reduction in efficacy.]
[L03AA12, ancestim, Tadalafil may decrease the excretion rate of Ancestim which could result in a higher serum level.]
[M01AH01, celecoxib, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Celecoxib.]
[N02CC02, naratriptan, Naratriptan may decrease the antihypertensive activities of Tadalafil.]
[N04AC01, benztropine, Benzatropine may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[L01EC02, dabrafenib, The serum concentration of Tadalafil can be decreased when it is combined with Dabrafenib.]
[R02AX03, benzydamine, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Benzydamine.]
[L01EE01, trametinib, Tadalafil may decrease the excretion rate of Trametinib which could result in a higher serum level.]
[V09AX05, florbetapir F-18, Tadalafil may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.]
[N06AX28, levomilnacipran, Tadalafil may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.]
[C08EA02, bepridil, Tadalafil may increase the hypotensive activities of Bepridil.]
[C02KX05, riociguat, The risk or severity of hypotension can be increased when Tadalafil is combined with Riociguat.]
[A10BJ03, lixisenatide, Tadalafil may decrease the excretion rate of Lixisenatide which could result in a higher serum level.]
[L01EL01, ibrutinib, The metabolism of Ibrutinib can be decreased when combined with Tadalafil.]
[N06AX26, vortioxetine, Vortioxetine may decrease the antihypertensive activities of Tadalafil.]
[G03AC08, etonogestrel, Etonogestrel may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[J05AP05, simeprevir, The metabolism of Tadalafil can be decreased when combined with Simeprevir.]
[S01EA03, apraclonidine, The risk or severity of hypotension can be increased when Tadalafil is combined with Apraclonidine.]
[J05AP08, sofosbuvir, Tadalafil may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[A10BK01, dapagliflozin, Dapagliflozin may increase the excretion rate of Tadalafil which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA27, droxidopa, Droxidopa may decrease the antihypertensive activities of Tadalafil.]
[C07AB04, acebutolol, Tadalafil may increase the hypotensive activities of Acebutolol.]
[N05CH03, tasimelteon, Tadalafil may decrease the excretion rate of Tasimelteon which could result in a higher serum level.]
[A16AA07, metreleptin, The metabolism of Tadalafil can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Tadalafil can be increased when combined with Apremilast.]
[L02BG02, formestane, Tadalafil may decrease the excretion rate of Formestane which could result in a higher serum level.]
[S03BA03, betamethasone, The metabolism of Tadalafil can be increased when combined with Betamethasone.]
[S01ED02, betaxolol, Betaxolol may increase the hypotensive activities of Tadalafil.]
[V03AB34, fomepizole, Tadalafil may decrease the excretion rate of Fomepizole which could result in a higher serum level.]
[C02CC01, bethanidine, Bethanidine may decrease the antihypertensive activities of Tadalafil.]
[L04AC11, siltuximab, The metabolism of Tadalafil can be increased when combined with Siltuximab.]
[A10BK03, empagliflozin, Empagliflozin may increase the hypotensive activities of Tadalafil.]
[R03AC19, olodaterol, Olodaterol may decrease the antihypertensive activities of Tadalafil.]
[V08AA01, diatrizoic acid, Diatrizoate may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[S01EE02, unoprostone, Tadalafil may increase the hypotensive activities of Unoprostone.]
[V08AA04, iothalamic acid, Diatrizoate may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[S01AA15, dihydrostreptomycin, Dihydrostreptomycin may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[N05AA04, acepromazine, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Acepromazine.]
[S03AA06, gentamicin, Tadalafil may decrease the excretion rate of Gentamicin which could result in a higher serum level.]
[L01XK01, olaparib, The metabolism of Olaparib can be decreased when combined with Tadalafil.]
[B01AF03, edoxaban, Tadalafil may decrease the excretion rate of Edoxaban which could result in a higher serum level.]
[N06AX11, mirtazapine, Mirtazapine may decrease the antihypertensive activities of Tadalafil.]
[L04AC10, secukinumab, The metabolism of Tadalafil can be increased when combined with Secukinumab.]
[J05AP07, daclatasvir, The metabolism of Daclatasvir can be decreased when combined with Tadalafil.]
[N02BE01, acetaminophen, Acetaminophen may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[L01DC01, bleomycin, Bleomycin may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[J05AF08, adefovir dipivoxil, Adefovir dipivoxil may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[J05AP06, asunaprevir, The metabolism of Asunaprevir can be decreased when combined with Tadalafil.]
[N05AX16, brexpiprazole, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Brexpiprazole.]
[G02CX02, flibanserin, Flibanserin may decrease the antihypertensive activities of Tadalafil.]
[N05AX15, cariprazine, Cariprazine may decrease the antihypertensive activities of Tadalafil.]
[M02AA25, aceclofenac, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Aceclofenac.]
[M01AB11, acemetacin, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Acemetacin.]
[S01EC01, acetazolamide, Acetazolamide may increase the excretion rate of Tadalafil which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB37, idarucizumab, Tadalafil may decrease the excretion rate of Idarucizumab which could result in a higher serum level.]
[J02AC05, isavuconazole, The metabolism of Tadalafil can be decreased when combined with Isavuconazole.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Tadalafil.]
[L01XG03, ixazomib, Tadalafil may decrease the excretion rate of Ixazomib which could result in a higher serum level.]
[B01AC27, selexipag, Tadalafil may increase the hypotensive activities of Selexipag.]
[G04CA01, alfuzosin, Alfuzosin may increase the hypotensive activities of Tadalafil.]
[M04AB05, lesinurad, Tadalafil may decrease the excretion rate of Lesinurad which could result in a higher serum level.]
[J05AP10, elbasvir, The metabolism of Elbasvir can be decreased when combined with Tadalafil.]
[M01AE16, alminoprofen, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Alminoprofen.]
[N03AX23, brivaracetam, Tadalafil may decrease the excretion rate of Brivaracetam which could result in a higher serum level.]
[L01XX52, venetoclax, The metabolism of Tadalafil can be decreased when combined with Venetoclax.]
[N05BA08, bromazepam, Tadalafil may decrease the excretion rate of Bromazepam which could result in a higher serum level.]
[N04BC01, bromocriptine, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Bromocriptine.]
[A02AD05, aluminum magnesium silicate, Tadalafil may decrease the excretion rate of Almasilate which could result in a higher serum level.]
[N06AA19, amineptin, Amineptine may decrease the antihypertensive activities of Tadalafil.]
[C08CA01, amlodipine, Amlodipine may increase the hypotensive activities of Tadalafil.]
[C03CA02, bumetanide, Bumetanide may increase the excretion rate of Tadalafil which could result in a lower serum level and potentially a reduction in efficacy.]
[S01ED03, levobunolol, The risk or severity of hypotension can be increased when Tadalafil is combined with Levobunolol.]
[N01BB01, bupivacaine, Bupivacaine may increase the hypotensive activities of Tadalafil.]
[C07AA19, bupranolol, Tadalafil may increase the hypotensive activities of Bupranolol.]
[N07BC01, buprenorphine, The metabolism of Buprenorphine can be decreased when combined with Tadalafil.]
[N05BE01, buspirone, Buspirone may decrease the antihypertensive activities of Tadalafil.]
[L01XX27, arsenic trioxide, Tadalafil may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.]
[P01BE02, artemether, The metabolism of Artemether can be decreased when combined with Tadalafil.]
[M02AA03, clofezone, Tadalafil may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[S01GX07, azelastine, The metabolism of Azelastine can be decreased when combined with Tadalafil.]
[L01XK03, rucaparib, The metabolism of Tadalafil can be decreased when combined with Rucaparib.]
[L01EF02, ribociclib, The serum concentration of Tadalafil can be increased when it is combined with Ribociclib.]
[A07EC04, balsalazide, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Balsalazide.]
[R03CC12, bambuterol, Bambuterol may decrease the antihypertensive activities of Tadalafil.]
[A06AH05, naldemedine, Tadalafil may decrease the excretion rate of Naldemedine which could result in a higher serum level.]
[N07XX16, deutetrabenazine, Tadalafil may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.]
[N02BF02, pregabalin, Pregabalin may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[C09AA07, benazepril, Benazepril may increase the hypotensive activities of Tadalafil.]
[P01CA02, benznidazole, Tadalafil may decrease the excretion rate of Benznidazole which could result in a higher serum level.]
[J01XX08, linezolid, Linezolid may increase the hypotensive activities of Tadalafil.]
[J05AF06, abacavir, Tadalafil may decrease the excretion rate of Abacavir which could result in a higher serum level.]
[J05AE09, tipranavir, The serum concentration of Tadalafil can be increased when it is combined with Tipranavir.]
[N07XX13, valbenazine, Tadalafil may decrease the excretion rate of Valbenazine which could result in a higher serum level.]
[L04AB02, infliximab, The metabolism of Tadalafil can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The serum concentration of Tadalafil can be increased when it is combined with Midostaurin.]
[N04BD03, safinamide, Safinamide may increase the hypotensive activities of Tadalafil.]
[J01MA23, delafloxacin, Tadalafil may decrease the excretion rate of Delafloxacin which could result in a higher serum level.]
[L01BC06, capecitabine, Tadalafil may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L01EM02, copanlisib, The metabolism of Copanlisib can be decreased when combined with Tadalafil.]
[C07AB07, bisoprolol, Bisoprolol may increase the hypotensive activities of Tadalafil.]
[R03AC17, bitolterol, Bitolterol may decrease the antihypertensive activities of Tadalafil.]
[J05AG03, efavirenz, The serum concentration of Tadalafil can be increased when it is combined with Efavirenz.]
[J01DC10, cefprozil, Cefprozil may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[C01DX19, nesiritide, Nesiritide may increase the hypotensive activities of Tadalafil.]
[C03DA03, canrenone, Canrenone may increase the excretion rate of Tadalafil which could result in a lower serum level and potentially a reduction in efficacy.]
[R03BA02, budesonide, The metabolism of Tadalafil can be increased when combined with Budesonide.]
[C04AX20, buflomedil, Buflomedil may decrease the antihypertensive activities of Tadalafil.]
[M01AB07, bumadizone, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Bumadizone.]
[L01EL02, acalabrutinib, The metabolism of Tadalafil can be decreased when combined with Acalabrutinib.]
[J05AX18, letermovir, The metabolism of Tadalafil can be decreased when combined with Letermovir.]
[N06AA15, butriptyline, Butriptyline may decrease the antihypertensive activities of Tadalafil.]
[A10BK04, ertugliflozin, Ertugliflozin may increase the excretion rate of Tadalafil which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AX18, acrivastine, Tadalafil may decrease the excretion rate of Acrivastine which could result in a higher serum level.]
[C09AA01, captopril, Tadalafil may increase the hypotensive activities of Captopril.]
[L02BB05, apalutamide, The metabolism of Tadalafil can be increased when combined with Apalutamide.]
[N03AF01, carbamazepine, The metabolism of Carbamazepine can be decreased when combined with Tadalafil.]
[C07AG02, carvedilol, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Carvedilol.]
[B02BX09, fostamatinib, The risk or severity of adverse effects can be increased when Tadalafil is combined with Fostamatinib.]
[N03AX24, cannabidiol, The metabolism of Tadalafil can be decreased when combined with Cannabidiol.]
[L04AA37, baricitinib, Tadalafil may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DE01, cefepime, Cefepime may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[J01DD10, cefetamet, Cefetamet may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[J01DD09, cefodizime, Cefodizime may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[J01DC11, ceforanide, Ceforanide may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[J01DD13, cefpodoxime, Cefpodoxime may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[J01DD14, ceftibuten, Ceftibuten may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[J01GB14, plazomicin, Tadalafil may decrease the excretion rate of Plazomicin which could result in a higher serum level.]
[C07AB08, celiprolol, Tadalafil may increase the hypotensive activities of Celiprolol.]
[L01XX62, ivosidenib, The metabolism of Tadalafil can be increased when combined with Ivosidenib.]
[A16AX14, migalastat, Tadalafil may decrease the excretion rate of Migalastat which could result in a higher serum level.]
[N03AX17, stiripentol, The serum concentration of Tadalafil can be increased when it is combined with Stiripentol.]
[J05AG06, doravirine, The metabolism of Doravirine can be decreased when combined with Tadalafil.]
[S01GX12, cetirizine, Cetirizine may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[D08AE05, chloroxylenol, Tadalafil may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.]
[M01AC05, lornoxicam, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Lornoxicam.]
[N07XX15, inotersen, Inotersen may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[L01ED05, lorlatinib, The metabolism of Lorlatinib can be decreased when combined with Tadalafil.]
[L04AA39, emapalumab, The metabolism of Tadalafil can be increased when combined with Emapalumab.]
[L01AD01, carmustine, Carmustine may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[A06AX05, prucalopride, Tadalafil may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C09AA08, cilazapril, Tadalafil may increase the hypotensive activities of Cilazapril.]
[B01AC23, cilostazol, Tadalafil may decrease the excretion rate of Cilostazol which could result in a higher serum level.]
[A03FA08, cinitapride, Cinitapride may decrease the antihypertensive activities of Tadalafil.]
[S01ED05, carteolol, Carteolol may increase the hypotensive activities of Tadalafil.]
[L04AA42, siponimod, Siponimod may decrease the antihypertensive activities of Tadalafil.]
[J01FA09, clarithromycin, The serum concentration of Tadalafil can be increased when it is combined with Clarithromycin.]
[N06BA14, solriamfetol, Solriamfetol may decrease the antihypertensive activities of Tadalafil.]
[N05BA09, clobazam, Clobazam may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[H02AB14, cloprednol, The metabolism of Tadalafil can be increased when combined with Cloprednol.]
[C09CA06, candesartan, Tadalafil may increase the hypotensive activities of Candesartan.]
[L04AB01, etanercept, The metabolism of Tadalafil can be increased when combined with Etanercept.]
[H02AB17, cortivazol, The metabolism of Tadalafil can be increased when combined with Cortivazol.]
[J01DC04, cefaclor, Cefaclor may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[J01DB05, cefadroxil, Cefadroxil may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[J01DC03, cefamandole, Cefamandole may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[J01DB07, cefatrizine, Cefatrizine may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[J01DB04, cefazolin, Cefazolin may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[J01DC09, cefmetazole, Cefmetazole may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[J01DC06, cefonicid, Cefonicid may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[J01DD12, cefoperazone, Cefoperazone may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[J01DD01, cefotaxime, Cefotaxime may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[J01DC05, cefotetan, Cefotetan may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[J01DC07, cefotiam, Cefotiam may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[J01DC01, cefoxitin, Cefoxitin may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[J01DD03, cefsulodin, Cefsulodin may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[J01DD02, ceftazidime, Ceftazidime may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[C03BX03, cicletanine, Cicletanine may increase the excretion rate of Tadalafil which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD07, ceftizoxime, Ceftizoxime may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[J01DD04, ceftriaxone, Ceftriaxone may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[S01AA27, cefuroxime, Cefuroxime may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[N07XX11, pitolisant, The serum concentration of Tadalafil can be decreased when it is combined with Pitolisant.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be decreased when combined with Tadalafil.]
[C03AA09, cyclothiazide, The therapeutic efficacy of Tadalafil can be increased when used in combination with Cyclothiazide.]
[G04BE04, yohimbine, Yohimbine may decrease the antihypertensive activities of Tadalafil.]
[J01XX09, daptomycin, Daptomycin may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[J01DB01, cephalexin, Cephalexin may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[J01DB02, cephaloridine, Cefaloridine may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[J01DB03, cephalothin, Cefalotin may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[J01DB08, cephapirin, Cefapirin may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[J01DB09, cephradine, Cefradine may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[L01FD03, ado-trastuzumab emtansine, The metabolism of Trastuzumab emtansine can be decreased when combined with Tadalafil.]
[N03AX25, cenobamate, The serum concentration of Tadalafil can be decreased when it is combined with Cenobamate.]
[A16AX16, givosiran, Givosiran may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[M09AX08, golodirsen, Tadalafil may decrease the excretion rate of Golodirsen which could result in a higher serum level.]
[S01XA12, dexpanthenol, Tadalafil may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.]
[N05CM21, lemborexant, The metabolism of Lemborexant can be decreased when combined with Tadalafil.]
[H02CA02, osilodrostat, The metabolism of Tadalafil can be decreased when combined with Osilodrostat.]
[J05AE05, amprenavir, The serum concentration of Tadalafil can be increased when it is combined with Amprenavir.]
[N02CC07, frovatriptan, Frovatriptan may decrease the antihypertensive activities of Tadalafil.]
[G04CB02, dutasteride, Dutasteride may decrease the antihypertensive activities of Tadalafil.]
[L01EE04, selumetinib, The metabolism of Selumetinib can be decreased when combined with Tadalafil.]
[R02AA03, dichlorobenzyl alcohol, Tadalafil may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.]
[G03DB08, dienogest, Tadalafil may decrease the excretion rate of Dienogest which could result in a higher serum level.]
[N02CC06, eletriptan, Eletriptan may decrease the antihypertensive activities of Tadalafil.]
[M01AH02, rofecoxib, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Rofecoxib.]
[C08CA16, clevidipine, Tadalafil may decrease the excretion rate of Clevidipine which could result in a higher serum level.]
[C01BD07, dronedarone, The metabolism of Dronedarone can be decreased when combined with Tadalafil.]
[S03AA08, chloramphenicol, The metabolism of Tadalafil can be decreased when combined with Chloramphenicol.]
[C02AA06, methoserpidine, Tadalafil may increase the hypotensive activities of Methoserpidine.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Tadalafil.]
[N04BX04, opicapone, Opicapone may increase the hypotensive activities of Tadalafil.]
[C01CA14, dopexamine, Dopexamine may decrease the antihypertensive activities of Tadalafil.]
[D07XB03, fluprednidene, The metabolism of Tadalafil can be increased when combined with Fluprednidene.]
[M01AC04, droxicam, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Droxicam.]
[V08CA05, mangafodipir, Tadalafil may decrease the excretion rate of Mangafodipir which could result in a higher serum level.]
[L01EX22, selpercatinib, Selpercatinib may decrease the antihypertensive activities of Tadalafil.]
[M02AA27, dexketoprofen, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Dexketoprofen.]
[C08CA17, levamlodipine, Tadalafil may increase the hypotensive activities of Levamlodipine.]
[L04AC19, satralizumab, The serum concentration of Tadalafil can be decreased when it is combined with Satralizumab.]
[P01BA01, chloroquine, Chloroquine may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[L01EX23, pralsetinib, The metabolism of Tadalafil can be decreased when combined with Pralsetinib.]
[C03AA04, chlorothiazide, The therapeutic efficacy of Tadalafil can be increased when used in combination with Chlorothiazide.]
[R06AB04, chlorpheniramine, The metabolism of Chlorpheniramine can be decreased when combined with Tadalafil.]
[N05AA01, chlorpromazine, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Chlorpromazine.]
[A10BB02, chlorpropamide, Chlorpropamide may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[C03BA04, chlorthalidone, Chlorthalidone may increase the excretion rate of Tadalafil which could result in a lower serum level and potentially a reduction in efficacy.]
[M03BB03, chlorzoxazone, Chlorzoxazone may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[N02BA07, ethenzamide, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Ethenzamide.]
[N02BA03, choline salicylate, Tadalafil may decrease the excretion rate of Choline salicylate which could result in a higher serum level.]
[M01AB08, etodolac, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Etodolac.]
[M02AA06, etofenamate, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Etofenamate.]
[B06AC06, berotralstat, The metabolism of Tadalafil can be decreased when combined with Berotralstat.]
[A16AX20, lonafarnib, The serum concentration of Tadalafil can be increased when it is combined with Lonafarnib.]
[L02BX04, relugolix, The metabolism of Relugolix can be decreased when combined with Tadalafil.]
[M01AX25, chondroitin sulfates, Tadalafil may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.]
[L01FX21, naxitamab, Naxitamab may decrease the antihypertensive activities of Tadalafil.]
[P03AX07, abametapir, The serum concentration of Tadalafil can be increased when it is combined with Abametapir.]
[C01DX22, vericiguat, The risk or severity of hypotension can be increased when Tadalafil is combined with Vericiguat.]
[M01AE05, fenbufen, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Fenbufen.]
[C01CA19, fenoldopam, Fenoldopam may increase the hypotensive activities of Tadalafil.]
[N06BA08, fenozolone, Fenozolone may decrease the antihypertensive activities of Tadalafil.]
[J01DD15, cefdinir, Cefdinir may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[N02BG07, flupirtine, Tadalafil may decrease the excretion rate of Flupirtine which could result in a higher serum level.]
[R03CC15, formoterol, Formoterol may decrease the antihypertensive activities of Tadalafil.]
[L04AA50, ponesimod, The metabolism of Ponesimod can be decreased when combined with Tadalafil.]
[N01AB05, trichloroethylene, Trichloroethylene may decrease the antihypertensive activities of Tadalafil.]
[H04AA02, dasiglucagon, Tadalafil may increase the hypotensive activities of Dasiglucagon.]
[A02BA01, cimetidine, The metabolism of Tadalafil can be decreased when combined with Cimetidine.]
[V08CA04, gadoteridol, Gadoteridol may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[L01XX73, sotorasib, The serum concentration of Tadalafil can be decreased when it is combined with Sotorasib.]
[S03AA07, ciprofloxacin, The metabolism of Tadalafil can be decreased when combined with Ciprofloxacin.]
[L01XA01, cisplatin, Tadalafil may decrease the excretion rate of Cisplatin which could result in a higher serum level.]
[C03DA05, finerenone, Finerenone may increase the excretion rate of Tadalafil which could result in a lower serum level and potentially a reduction in efficacy.]
[P01CA03, fexinidazole, The metabolism of Fexinidazole can be decreased when combined with Tadalafil.]
[L01EB10, mobocertinib, The metabolism of Mobocertinib can be decreased when combined with Tadalafil.]
[V09AB03, ioflupane I-123, Tadalafil may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.]
[V09AA01, technetium Tc 99m exametazime, Tadalafil may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.]
[V09AX06, florbetaben f-18, Tadalafil may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.]
[R03CC13, clenbuterol, Clenbuterol may decrease the antihypertensive activities of Tadalafil.]
[J01FF01, clindamycin, The metabolism of Clindamycin can be decreased when combined with Tadalafil.]
[N06AX25, St. John's wort extract, The metabolism of Tadalafil can be increased when combined with St. John's Wort.]
[J04BA01, clofazimine, The metabolism of Tadalafil can be decreased when combined with Clofazimine.]
[N01BB10, levobupivacaine, Tadalafil may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.]
[N06AA04, clomipramine, Clomipramine may decrease the antihypertensive activities of Tadalafil.]
[N03AE01, clonazepam, Tadalafil may decrease the excretion rate of Clonazepam which could result in a higher serum level.]
[S01EA04, clonidine, The risk or severity of hypotension can be increased when Clonidine is combined with Tadalafil.]
[C01EB24, mavacamten, The serum concentration of Tadalafil can be decreased when it is combined with Mavacamten.]
[J05AH02, oseltamivir, Oseltamivir may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[C03BA03, clopamide, Clopamide may increase the excretion rate of Tadalafil which could result in a lower serum level and potentially a reduction in efficacy.]
[A02BC08, vonoprazan, The metabolism of Vonoprazan can be decreased when combined with Tadalafil.]
[A04AA01, ondansetron, The metabolism of Ondansetron can be decreased when combined with Tadalafil.]
[L01XX77, adagrasib, The serum concentration of Tadalafil can be increased when it is combined with Adagrasib.]
[N05AH02, clozapine, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Clozapine.]
[J01GB12, arbekacin, Tadalafil may decrease the excretion rate of Arbekacin which could result in a higher serum level.]
[H01AC08, somatrogon, The metabolism of Tadalafil can be increased when combined with Somatrogon.]
[C02KB01, metyrosine, Metyrosine may increase the hypotensive activities of Tadalafil.]
[L04AC21, bimekizumab, The metabolism of Tadalafil can be increased when combined with Bimekizumab.]
[M01AX13, proquazone, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Proquazone.]
[M04AC01, colchicine, Tadalafil may decrease the excretion rate of Colchicine which could result in a higher serum level.]
[J01XB01, colistin, Tadalafil may decrease the excretion rate of Colistin which could result in a higher serum level.]
[J01DE02, cefpirome, Cefpirome may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[N01AB07, desflurane, Desflurane may decrease the antihypertensive activities of Tadalafil.]
[A04AA03, tropisetron, Tadalafil may decrease the excretion rate of Tropisetron which could result in a higher serum level.]
[C04AX28, ifenprodil, Ifenprodil may decrease the antihypertensive activities of Tadalafil.]
[A10BX03, nateglinide, Nateglinide may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[N02BA16, imidazole-2-hydroxybenzoate, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Imidazole salicylate.]
[J01FA15, telithromycin, The serum concentration of Tadalafil can be increased when it is combined with Telithromycin.]
[B01AC10, indobufen, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Indobufen.]
[J05AB14, valganciclovir, Tadalafil may decrease the excretion rate of Valganciclovir which could result in a higher serum level.]
[C05BB03, invert sugar, Tadalafil may decrease the excretion rate of Invert sugar which could result in a higher serum level.]
[V08AB09, iodixanol, Tadalafil may decrease the excretion rate of Iodixanol which could result in a higher serum level.]
[V08AB05, iopromide, Tadalafil may decrease the excretion rate of Iopromide which could result in a higher serum level.]
[V08AB07, ioversol, Tadalafil may decrease the excretion rate of Ioversol which could result in a higher serum level.]
[V08AB12, ioxilan, Tadalafil may decrease the excretion rate of Ioxilan which could result in a higher serum level.]
[M01AH03, valdecoxib, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Valdecoxib.]
[A03AX10, isometheptene, Isometheptene may decrease the antihypertensive activities of Tadalafil.]
[N02CC05, almotriptan, Almotriptan may decrease the antihypertensive activities of Tadalafil.]
[M01AH04, parecoxib, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Parecoxib.]
[J02AC02, itraconazole, The metabolism of Tadalafil can be decreased when combined with Itraconazole.]
[S01AD03, acyclovir, Acyclovir may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[N05BA10, ketazolam, Tadalafil may decrease the excretion rate of Ketazolam which could result in a higher serum level.]
[M01AA06, kebuzone, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Kebuzone.]
[L01EA01, imatinib, The metabolism of Tadalafil can be decreased when combined with Imatinib.]
[J02AC04, posaconazole, The serum concentration of Tadalafil can be increased when it is combined with Posaconazole.]
[S01EE04, travoprost, Travoprost may increase the hypotensive activities of Tadalafil.]
[S01EE03, bimatoprost, Tadalafil may increase the hypotensive activities of Bimatoprost.]
[C08CA09, lacidipine, Tadalafil may increase the hypotensive activities of Lacidipine.]
[N03AX09, lamotrigine, Lamotrigine may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[S01BA03, cortisone, The metabolism of Tadalafil can be increased when combined with Cortisone.]
[N07BC04, lofexidine, Lofexidine may decrease the antihypertensive activities of Tadalafil.]
[M01AB09, lonazolac, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Lonazolac.]
[M02AA31, loxoprofen, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Loxoprofen.]
[J01DC08, loracarbef, Loracarbef may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[C09AA03, lisinopril, Lisinopril may increase the hypotensive activities of Tadalafil.]
[A06AD01, magnesium carbonate, Tadalafil may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.]
[C08CA11, manidipine, Tadalafil may increase the hypotensive activities of Manidipine.]
[A08AA09, mefenorex, Mefenorex may decrease the antihypertensive activities of Tadalafil.]
[H02AB15, meprednisone, The metabolism of Tadalafil can be increased when combined with Meprednisone.]
[J01DH02, meropenem, Meropenem may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[R03CB02, methoxyphenamine, Methoxyphenamine may decrease the antihypertensive activities of Tadalafil.]
[C03DA04, eplerenone, Eplerenone may increase the excretion rate of Tadalafil which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AD03, metylperon, Tadalafil may decrease the excretion rate of Melperone which could result in a higher serum level.]
[C03AA07, cyclopenthiazide, The therapeutic efficacy of Tadalafil can be increased when used in combination with Cyclopenthiazide.]
[J05AF07, tenofovir disoproxil, Tenofovir disoproxil may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be decreased when combined with Tadalafil.]
[N06AX07, minaprine, Minaprine may increase the hypotensive activities of Tadalafil.]
[S01XA18, cyclosporine, The metabolism of Cyclosporine can be decreased when combined with Tadalafil.]
[N06AG02, moclobemide, Moclobemide may increase the hypotensive activities of Tadalafil.]
[N06BA07, modafinil, The metabolism of Tadalafil can be increased when combined with Modafinil.]
[C09AA13, moexipril, Moexipril may increase the hypotensive activities of Tadalafil.]
[C10AA07, rosuvastatin, The metabolism of Rosuvastatin can be decreased when combined with Tadalafil.]
[M02AA02, mofebutazone, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Mofebutazone.]
[M01AX22, morniflumate, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Morniflumate.]
[C03XA02, conivaptan, The serum concentration of Tadalafil can be increased when it is combined with Conivaptan.]
[C02AC05, moxonidine, Moxonidine may decrease the antihypertensive activities of Tadalafil.]
[G04BE09, vardenafil, The risk or severity of adverse effects can be increased when Tadalafil is combined with Vardenafil.]
[M01AH05, etoricoxib, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Etoricoxib.]
[L01AX04, dacarbazine, Tadalafil may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[G03XA01, danazol, The serum concentration of Tadalafil can be increased when it is combined with Danazol.]
[J04BA02, dapsone, The metabolism of Tadalafil can be decreased when combined with Dapsone.]
[L01DB02, daunorubicin, The metabolism of Tadalafil can be increased when combined with Daunorubicin.]
[C02CC04, debrisoquin, Tadalafil may increase the hypotensive activities of Debrisoquine.]
[A04AD11, nabilone, Nabilone may increase the hypotensive activities of Tadalafil.]
[M01AX01, nabumetone, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Nabumetone.]
[N07BB05, nalmefene, Tadalafil may decrease the excretion rate of Nalmefene which could result in a higher serum level.]
[C07AB12, nebivolol, Tadalafil may increase the hypotensive activities of Nebivolol.]
[S01GX04, nedocromil, Nedocromil may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[N06AX06, nefazodone, The serum concentration of Tadalafil can be increased when it is combined with Nefazodone.]
[C01DX16, nicorandil, Tadalafil may increase the hypotensive activities of Nicorandil.]
[L02BB02, nilutamide, Nilutamide may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[C01CA23, theodrenaline, Theodrenaline may decrease the antihypertensive activities of Tadalafil.]
[C01CA05, norfenefrine, Norfenefrine may decrease the antihypertensive activities of Tadalafil.]
[B01AX05, fondaparinux, Fondaparinux may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[G04BD08, solifenacin, Solifenacin may decrease the antihypertensive activities of Tadalafil.]
[A07EC03, olsalazine, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Olsalazine.]
[N06AA01, desipramine, Desipramine may decrease the antihypertensive activities of Tadalafil.]
[H01BA02, desmopressin, Desmopressin may decrease the antihypertensive activities of Tadalafil.]
[V04CH02, indigo carmine, Tadalafil may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[J01DH03, ertapenem, Ertapenem may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[C09XA02, aliskiren, Tadalafil may increase the hypotensive activities of Aliskiren.]
[M01AE12, oxaprozin, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Oxaprozin.]
[N03AF02, oxcarbazepine, The metabolism of Tadalafil can be increased when combined with Oxcarbazepine.]
[S03BA01, dexamethasone, The metabolism of Tadalafil can be increased when combined with Dexamethasone.]
[G04BD04, oxybutynin, The metabolism of Oxybutynin can be decreased when combined with Tadalafil.]
[L04AB04, adalimumab, The metabolism of Tadalafil can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, The metabolism of Tadalafil can be decreased when combined with Gefitinib.]
[N06BA02, dextroamphetamine, Amphetamine may decrease the antihypertensive activities of Tadalafil.]
[R05DA09, dextromethorphan, The metabolism of Tadalafil can be decreased when combined with Dextromethorphan.]
[B01AC04, clopidogrel, The metabolism of Tadalafil can be decreased when combined with Clopidogrel.]
[P03AC04, permethrin, Tadalafil may decrease the excretion rate of Permethrin which could result in a higher serum level.]
[N05BA01, diazepam, Tadalafil may decrease the excretion rate of Diazepam which could result in a higher serum level.]
[V03AH01, diazoxide, Diazoxide may increase the hypotensive activities of Tadalafil.]
[N06AA08, dibenzepin, Dibenzepin may decrease the antihypertensive activities of Tadalafil.]
[R05DA08, pholcodine, Tadalafil may decrease the excretion rate of Pholcodine which could result in a higher serum level.]
[S01EC02, dichlorphenamide, Diclofenamide may increase the excretion rate of Tadalafil which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC03, diclofenac, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Diclofenac.]
[J05AD01, foscarnet, Foscarnet may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[A03AA07, dicyclomine, Dicyclomine may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[J05AF02, didanosine, Tadalafil may decrease the excretion rate of Didanosine which could result in a higher serum level.]
[C02DG01, pinacidil, Tadalafil may increase the hypotensive activities of Pinacidil.]
[N05AD05, pipamperone, Pipamperone may increase the hypotensive activities of Tadalafil.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be decreased when combined with Tadalafil.]
[R03CC07, pirbuterol, Pirbuterol may decrease the antihypertensive activities of Tadalafil.]
[C03CA03, piretanide, Piretanide may increase the excretion rate of Tadalafil which could result in a lower serum level and potentially a reduction in efficacy.]
[A08AA03, diethylpropion, Diethylpropion may decrease the antihypertensive activities of Tadalafil.]
[C08CA03, isradipine, The metabolism of Tadalafil can be decreased when combined with Isradipine.]
[D07XC04, diflucortolone, The metabolism of Tadalafil can be increased when combined with Difluocortolone.]
[N02BA11, diflunisal, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Diflunisal.]
[C01AA05, digoxin, Tadalafil may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[C02DB01, dihydralazine, Tadalafil may increase the hypotensive activities of Dihydralazine.]
[C04AE04, dihydroergocristine, Dihydroergocristine may decrease the antihypertensive activities of Tadalafil.]
[N02CA01, dihydroergotamine, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Dihydroergotamine.]
[N02AA03, hydromorphone, Hydromorphone may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[L04AX04, lenalidomide, Lenalidomide may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[J05AE08, atazanavir, The serum concentration of Tadalafil can be increased when it is combined with Atazanavir.]
[B01AC21, treprostinil, Treprostinil may increase the hypotensive activities of Tadalafil.]
[H03BC01, potassium perchlorate, Tadalafil may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.]
[V03AB04, pralidoxime, Pralidoxime may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[C08DB01, diltiazem, The metabolism of Tadalafil can be decreased when combined with Diltiazem.]
[V03AB09, dimercaprol, Tadalafil may decrease the excretion rate of Dimercaprol which could result in a higher serum level.]
[R03CC08, procaterol, Procaterol may decrease the antihypertensive activities of Tadalafil.]
[M02AX03, dimethyl sulfoxide, Tadalafil may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.]
[N02BB04, propyphenazone, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Propyphenazone.]
[M01AB14, proglumetacin, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Proglumetacin.]
[C09AA06, quinapril, Tadalafil may increase the hypotensive activities of Quinapril.]
[B01AC07, dipyridamole, The risk or severity of adverse effects can be increased when Tadalafil is combined with Dipyridamole.]
[N06BA11, dexmethylphenidate, Dexmethylphenidate may decrease the antihypertensive activities of Tadalafil.]
[N06AA23, quinupramine, Quinupramine may decrease the antihypertensive activities of Tadalafil.]
[A03FA02, cisapride, The metabolism of Tadalafil can be decreased when combined with Cisapride.]
[C09AA05, ramipril, Ramipril may increase the hypotensive activities of Tadalafil.]
[S01XA23, sirolimus, The metabolism of Sirolimus can be decreased when combined with Tadalafil.]
[R03CC14, reproterol, Reproterol may decrease the antihypertensive activities of Tadalafil.]
[S01AX06, resorcinol, Tadalafil may decrease the excretion rate of Resorcinol which could result in a higher serum level.]
[C01BA03, disopyramide, Disopyramide may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[P03AA04, disulfiram, The metabolism of Disulfiram can be decreased when combined with Tadalafil.]
[S02AA12, rifamycin SV, The metabolism of Tadalafil can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Tadalafil can be increased when combined with Rifapentine.]
[N05AX08, risperidone, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Risperidone.]
[R06AE09, levocetirizine, Tadalafil may decrease the excretion rate of Levocetirizine which could result in a higher serum level.]
[N01BB09, ropivacaine, Ropivacaine may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[L01EX01, sunitinib, The metabolism of Sunitinib can be decreased when combined with Tadalafil.]
[A04AD12, aprepitant, The metabolism of Tadalafil can be decreased when combined with Aprepitant.]
[C03XA01, tolvaptan, Tolvaptan may increase the excretion rate of Tadalafil which could result in a lower serum level and potentially a reduction in efficacy.]
[S01AA13, fusidic acid, The metabolism of Tadalafil can be decreased when combined with Fusidic acid.]
[S02BA08, fluocinolone acetonide, Fluocinolone acetonide may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[M01AG01, mefenamic acid, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Mefenamic acid.]
[C01DA05, pentaerythritol tetranitrate, The risk or severity of hypotension can be increased when Tadalafil is combined with Pentaerythritol tetranitrate.]
[S01BC05, ketorolac, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Ketorolac.]
[C02KX02, ambrisentan, Tadalafil may increase the hypotensive activities of Ambrisentan.]
[C01EB18, ranolazine, Ranolazine may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[N02BA06, salsalate, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Salsalate.]
[R03AC12, salmeterol, Salmeterol may decrease the antihypertensive activities of Tadalafil.]
[H05BA01, salmon calcitonin, Salmon calcitonin may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[C01CA07, dobutamine, Dobutamine may decrease the antihypertensive activities of Tadalafil.]
[A03FA03, domperidone, The metabolism of Domperidone can be decreased when combined with Tadalafil.]
[C01CA04, dopamine, Dopamine may decrease the antihypertensive activities of Tadalafil.]
[N06AA16, dothiepin, Dosulepin may decrease the antihypertensive activities of Tadalafil.]
[R07AB01, doxapram, Doxapram may decrease the antihypertensive activities of Tadalafil.]
[N06AA12, doxepin, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Doxepin.]
[J01AA02, doxycycline, Doxycycline may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[N01AB08, sevoflurane, Sevoflurane may decrease the antihypertensive activities of Tadalafil.]
[N05AD08, droperidol, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Droperidol.]
[A08AA10, sibutramine, Tadalafil may decrease the excretion rate of Sibutramine which could result in a higher serum level.]
[C10AA01, simvastatin, The metabolism of Tadalafil can be decreased when combined with Simvastatin.]
[A12CA02, sodium sulfate, Tadalafil may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.]
[C09AA11, spirapril, Tadalafil may increase the hypotensive activities of Spirapril.]
[R03DA01, dyphylline, Dyphylline may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[N02CC01, sumatriptan, Sumatriptan may decrease the antihypertensive activities of Tadalafil.]
[V04CX07, edrophonium, Tadalafil may decrease the excretion rate of Edrophonium which could result in a higher serum level.]
[C07AB13, talinolol, Tadalafil may increase the hypotensive activities of Talinolol.]
[L01AX03, temozolomide, Tadalafil may decrease the excretion rate of Temozolomide which could result in a higher serum level.]
[M01AC02, tenoxicam, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Tenoxicam.]
[G04CA03, terazosin, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Terazosin.]
[S01GA02, tetrahydrozoline, Tetryzoline may decrease the antihypertensive activities of Tadalafil.]
[N06AX14, tianeptine, Tianeptine may decrease the antihypertensive activities of Tadalafil.]
[C09AA02, enalapril, Enalapril may increase the hypotensive activities of Tadalafil.]
[M01AG02, tolfenamic acid, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Tolfenamic acid.]
[N06AG03, toloxatone, Toloxatone may increase the hypotensive activities of Tadalafil.]
[N06BA09, atomoxetine, Atomoxetine may decrease the antihypertensive activities of Tadalafil.]
[N03AX11, topiramate, Topiramate may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[C03CA04, torsemide, Torasemide may increase the excretion rate of Tadalafil which could result in a lower serum level and potentially a reduction in efficacy.]
[R01AA09, tramazoline, Tramazoline may decrease the antihypertensive activities of Tadalafil.]
[C09AA10, trandolapril, Trandolapril may increase the hypotensive activities of Tadalafil.]
[R03CC11, tulobuterol, Tulobuterol may decrease the antihypertensive activities of Tadalafil.]
[C02CA06, urapidil, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Urapidil.]
[S01FB02, ephedrine, Ephedrine may decrease the antihypertensive activities of Tadalafil.]
[N06AX16, venlafaxine, Venlafaxine may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[C01CX07, xamoterol, Xamoterol may decrease the antihypertensive activities of Tadalafil.]
[S01GA03, xylometazoline, Xylometazoline may decrease the antihypertensive activities of Tadalafil.]
[C08CA12, mepirodipine, Tadalafil may increase the antihypertensive activities of Barnidipine.]
[S01EA01, epinephrine, Epinephrine may decrease the antihypertensive activities of Tadalafil.]
[C09AA15, zofenopril, Tadalafil may increase the hypotensive activities of Zofenopril.]
[M01AB04, zomepirac, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Zomepirac.]
[N03AX15, zonisamide, Zonisamide may increase the excretion rate of Tadalafil which could result in a lower serum level and potentially a reduction in efficacy.]
[L01XA02, carboplatin, Carboplatin may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[C02AC02, guanfacine, Guanfacine may decrease the antihypertensive activities of Tadalafil.]
[B01AC11, iloprost, Iloprost may increase the hypotensive activities of Tadalafil.]
[G02AB03, ergonovine, Ergometrine may decrease the antihypertensive activities of Tadalafil.]
[C04AE01, ergoloid mesylates, USP, Ergoloid mesylate may decrease the antihypertensive activities of Tadalafil.]
[N02CA02, ergotamine, The serum concentration of Tadalafil can be increased when it is combined with Ergotamine.]
[C01DA13, erythrityl tetranitrate, The risk or severity of hypotension can be increased when Tadalafil is combined with Erythrityl tetranitrate.]
[L03AX05, pidotimod, Tadalafil may decrease the excretion rate of Pidotimod which could result in a higher serum level.]
[S01AA17, erythromycin, The metabolism of Tadalafil can be decreased when combined with Erythromycin.]
[N05CD04, estazolam, Tadalafil may decrease the excretion rate of Estazolam which could result in a higher serum level.]
[A02BC02, pantoprazole, Pantoprazole may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[G03CA03, estradiol, Estradiol may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[J04AK02, ethambutol, Ethambutol may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[R03BA09, fluticasone furoate, The metabolism of Tadalafil can be decreased when combined with Fluticasone furoate.]
[R03BA05, fluticasone, The metabolism of Tadalafil can be decreased when combined with Fluticasone.]
[C10AA04, fluvastatin, The metabolism of Fluvastatin can be decreased when combined with Tadalafil.]
[V08CA03, gadodiamide, Gadodiamide may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[C01CA15, gepefrine, Gepefrine may decrease the antihypertensive activities of Tadalafil.]
[L02AA03, ethinyl estradiol, The metabolism of Ethinylestradiol can be decreased when combined with Tadalafil.]
[V03AF05, amifostine, Tadalafil may increase the hypotensive activities of Amifostine.]
[C01BD05, ibutilide, Ibutilide may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[M01AC06, meloxicam, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Meloxicam.]
[C01CA01, etilefrine, Etilefrine may decrease the antihypertensive activities of Tadalafil.]
[N01AX07, etomidate, Etomidate may decrease the antihypertensive activities of Tadalafil.]
[L01CB01, etoposide, The metabolism of Etoposide can be decreased when combined with Tadalafil.]
[L04AD02, tacrolimus, The metabolism of Tacrolimus can be decreased when combined with Tadalafil.]
[R06AX11, astemizole, The metabolism of Astemizole can be decreased when combined with Tadalafil.]
[R06AX12, terfenadine, The serum concentration of Tadalafil can be increased when it is combined with Terfenadine.]
[P01AX07, trimetrexate, Tadalafil may decrease the excretion rate of Trimetrexate which could result in a higher serum level.]
[N06AX12, bupropion, Tadalafil may decrease the excretion rate of Bupropion which could result in a higher serum level.]
[N06AB08, fluvoxamine, The metabolism of Tadalafil can be decreased when combined with Fluvoxamine.]
[L02AE02, leuprolide, Leuprolide may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[M01CB01, gold sodium thiomalate, Tadalafil may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.]
[B05AA05, dextran, Tadalafil may decrease the excretion rate of Dextran which could result in a higher serum level.]
[V03AF02, dexrazoxane, Dexrazoxane may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[A16AA01, levocarnitine, Levocarnitine may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[C08CA02, felodipine, Tadalafil may increase the hypotensive activities of Felodipine.]
[M01AE04, fenoprofen, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Fenoprofen.]
[R03CC04, fenoterol, Fenoterol may decrease the antihypertensive activities of Tadalafil.]
[N02AB03, fentanyl, Fentanyl may decrease the antihypertensive activities of Tadalafil.]
[R03CC02, albuterol, Salbutamol may decrease the antihypertensive activities of Tadalafil.]
[L01BB06, clofarabine, Clofarabine may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[N07AX03, cevimeline, Cevimeline may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[G04BD02, flavoxate, Tadalafil may decrease the excretion rate of Flavoxate which could result in a higher serum level.]
[N02BG04, floctafenine, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Floctafenine.]
[J02AC01, fluconazole, The metabolism of Tadalafil can be decreased when combined with Fluconazole.]
[J02AX01, flucytosine, Tadalafil may decrease the excretion rate of Flucytosine which could result in a higher serum level.]
[V03AB25, flumazenil, Tadalafil may decrease the excretion rate of Flumazenil which could result in a higher serum level.]
[D07AC08, fluocinonide, The metabolism of Tadalafil can be increased when combined with Fluocinonide.]
[N06AA14, melitracen, Melitracen may decrease the antihypertensive activities of Tadalafil.]
[H02AB03, fluocortolone, The metabolism of Tadalafil can be increased when combined with Fluocortolone.]
[V03AZ01, ethanol, Ethanol may increase the hypotensive activities of Tadalafil.]
[L01BC09, floxuridine, Floxuridine may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[N05AF01, flupenthixol, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Flupentixol.]
[N05CD01, flurazepam, Flurazepam may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[S01BC04, flurbiprofen, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Flurbiprofen.]
[L02BB01, flutamide, Flutamide may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[V04CX02, folic acid, Folic acid may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[S02AA17, fosfomycin, Tadalafil may decrease the excretion rate of Fosfomycin which could result in a higher serum level.]
[S01AA07, framycetin, Framycetin may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[L01BC03, tegafur, The metabolism of Tegafur can be decreased when combined with Tadalafil.]
[N06BX17, adrafinil, Adrafinil may decrease the antihypertensive activities of Tadalafil.]
[G01AX06, furazolidone, Furazolidone may increase the hypotensive activities of Tadalafil.]
[J05AE10, darunavir, The serum concentration of Tadalafil can be increased when it is combined with Darunavir.]
[C03CA01, furosemide, Furosemide may increase the excretion rate of Tadalafil which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CF04, eszopiclone, Eszopiclone may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[S01AD09, ganciclovir, Tadalafil may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C10AB04, gemfibrozil, Tadalafil may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.]
[J01XA03, telavancin, Tadalafil may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01EA02, dasatinib, The metabolism of Dasatinib can be decreased when combined with Tadalafil.]
[N04BC06, cabergoline, Cabergoline may decrease the antihypertensive activities of Tadalafil.]
[N01AH02, alfentanil, Alfentanil may decrease the antihypertensive activities of Tadalafil.]
[L01EH01, lapatinib, The metabolism of Lapatinib can be decreased when combined with Tadalafil.]
[A10BB01, glyburide, The metabolism of Glyburide can be decreased when combined with Tadalafil.]
[A10BB07, glipizide, Tadalafil may decrease the excretion rate of Glipizide which could result in a higher serum level.]
[N05CM18, dexmedetomidine, Dexmedetomidine may decrease the antihypertensive activities of Tadalafil.]
[C05AE01, nitroglycerin, The risk or severity of hypotension can be increased when Tadalafil is combined with Nitroglycerin.]
[C02CA04, doxazosin, The risk or severity of hypotension can be increased when Tadalafil is combined with Doxazosin.]
[L01EX02, sorafenib, The metabolism of Sorafenib can be decreased when combined with Tadalafil.]
[C07AB09, esmolol, Esmolol may increase the hypotensive activities of Tadalafil.]
[M01CB04, aurothioglucose, Tadalafil may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.]
[S01LA03, pegaptanib, Tadalafil may decrease the excretion rate of Pegaptanib which could result in a higher serum level.]
[C09AA09, fosinopril, Fosinopril may increase the hypotensive activities of Tadalafil.]
[S01EX01, guanethidine, Tadalafil may increase the hypotensive activities of Guanethidine.]
[L02AE03, goserelin, Goserelin may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[P01BX01, halofantrine, The metabolism of Halofantrine can be decreased when combined with Tadalafil.]
[N05AD01, haloperidol, The serum concentration of Haloperidol can be increased when it is combined with Tadalafil.]
[N01AB01, halothane, Halothane may decrease the antihypertensive activities of Tadalafil.]
[N05AH04, quetiapine, Quetiapine may increase the hypotensive activities of Tadalafil.]
[N06BX13, idebenone, Tadalafil may decrease the excretion rate of Idebenone which could result in a higher serum level.]
[L01CE02, irinotecan, The metabolism of Tadalafil can be decreased when combined with Irinotecan.]
[M04AA01, allopurinol, Allopurinol may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[C09CA01, losartan, Losartan may increase the hypotensive activities of Tadalafil.]
[G03DC01, allylestrenol, Tadalafil may decrease the excretion rate of Allylestrenol which could result in a higher serum level.]
[A07EC02, mesalamine, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Mesalazine.]
[C01CE02, milrinone, Milrinone may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[R03CC05, hexoprenaline, Hexoprenaline may decrease the antihypertensive activities of Tadalafil.]
[J05AG01, nevirapine, The metabolism of Tadalafil can be decreased when combined with Nevirapine.]
[C08CA10, nilvadipine, The metabolism of Tadalafil can be decreased when combined with Nilvadipine.]
[M02AA26, nimesulide, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Nimesulide.]
[C09AA04, perindopril, Perindopril may increase the hypotensive activities of Tadalafil.]
[C02DB02, hydralazine, Tadalafil may increase the hypotensive activities of Hydralazine.]
[C03AA03, hydrochlorothiazide, The therapeutic efficacy of Tadalafil can be increased when used in combination with Hydrochlorothiazide.]
[S02BA01, hydrocortisone, The metabolism of Tadalafil can be decreased when combined with Hydrocortisone.]
[C03AA02, hydroflumethiazide, The therapeutic efficacy of Tadalafil can be increased when used in combination with Hydroflumethiazide.]
[B05XA17, potassium acetate, Tadalafil may decrease the excretion rate of Potassium acetate which could result in a higher serum level.]
[A12BA02, potassium citrate, Potassium citrate may increase the excretion rate of Tadalafil which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB33, hydroxocobalamin, Hydroxocobalamin may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[G04BD06, propiverine, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Propiverine.]
[B05AA07, hetastarch, Tadalafil may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.]
[N05BB01, hydroxyzine, The metabolism of Tadalafil can be decreased when combined with Hydroxyzine.]
[C02AC06, rilmenidine, Rilmenidine may decrease the antihypertensive activities of Tadalafil.]
[R02AX02, ibuprofen, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Ibuprofen.]
[B05XA08, sodium acetate, Tadalafil may decrease the excretion rate of Sodium acetate which could result in a higher serum level.]
[L01AA06, ifosfamide, The metabolism of Ifosfamide can be decreased when combined with Tadalafil.]
[N01AH03, sufentanil, Sufentanil may decrease the antihypertensive activities of Tadalafil.]
[N06AA02, imipramine, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Imipramine.]
[L01CD01, paclitaxel, The metabolism of Paclitaxel can be decreased when combined with Tadalafil.]
[R01AD07, tixocortol, Tadalafil may decrease the excretion rate of Tixocortol which could result in a higher serum level.]
[M03BX02, tizanidine, Tizanidine may increase the hypotensive activities of Tadalafil.]
[L01CE01, topotecan, Tadalafil may decrease the excretion rate of Topotecan which could result in a higher serum level.]
[C03BA11, indapamide, The therapeutic efficacy of Indapamide can be increased when used in combination with Tadalafil.]
[S01BC01, indomethacin, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Indomethacin.]
[C02CA02, indoramin, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Indoramin.]
[A11HA07, inositol, Tadalafil may decrease the excretion rate of Inositol which could result in a higher serum level.]
[N06AX17, milnacipran, The metabolism of Tadalafil can be decreased when combined with Milnacipran.]
[S01XA28, varenicline, Tadalafil may decrease the excretion rate of Varenicline which could result in a higher serum level.]
[A10BH01, sitagliptin, Tadalafil may decrease the excretion rate of Sitagliptin which could result in a higher serum level.]
[N05BA12, alprazolam, Alprazolam may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[N05CH02, ramelteon, Tadalafil may decrease the excretion rate of Ramelteon which could result in a higher serum level.]
[C10AA06, cerivastatin, The metabolism of Tadalafil can be decreased when combined with Cerivastatin.]
[C07AA01, alprenolol, Tadalafil may increase the hypotensive activities of Alprenolol.]
[C03BA02, quinethazone, Quinethazone may increase the excretion rate of Tadalafil which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB01, ipecac, Tadalafil may decrease the excretion rate of Ipecac which could result in a higher serum level.]
[N06AA13, iprindole, Iprindole may decrease the antihypertensive activities of Tadalafil.]
[G04BE01, alprostadil, The risk or severity of hypotension and priapism can be increased when Tadalafil is combined with Alprostadil.]
[N06AF05, iproniazid, Iproniazid may increase the hypotensive activities of Tadalafil.]
[N06AF01, isocarboxazid, Isocarboxazid may increase the hypotensive activities of Tadalafil.]
[S01EC03, dorzolamide, Tadalafil may increase the hypotensive activities of Dorzolamide.]
[R03CC06, isoetharine, Isoetharine may decrease the antihypertensive activities of Tadalafil.]
[C09AA16, imidapril, Tadalafil may increase the hypotensive activities of Imidapril.]
[N01AB06, isoflurane, Isoflurane may decrease the antihypertensive activities of Tadalafil.]
[J04AC01, isoniazid, The metabolism of Tadalafil can be decreased when combined with Isoniazid.]
[J05AX05, inosine pranobex, Tadalafil may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.]
[R03CB01, isoproterenol, Isoprenaline may decrease the antihypertensive activities of Tadalafil.]
[C05AE02, isosorbide dinitrate, The risk or severity of hypotension can be increased when Tadalafil is combined with Isosorbide dinitrate.]
[D10BA01, isotretinoin, Tadalafil may decrease the excretion rate of Isotretinoin which could result in a higher serum level.]
[C04AA01, isoxsuprine, Isoxsuprine may decrease the antihypertensive activities of Tadalafil.]
[S01AA24, kanamycin, Tadalafil may decrease the excretion rate of Kanamycin which could result in a higher serum level.]
[L04AC07, tocilizumab, The metabolism of Tadalafil can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, Tadalafil may decrease the excretion rate of Ketamine which could result in a higher serum level.]
[C02KD01, ketanserin, Tadalafil may increase the hypotensive activities of Ketanserin.]
[B01AC22, prasugrel, Tadalafil may decrease the excretion rate of Prasugrel which could result in a higher serum level.]
[J02AB02, ketoconazole, The serum concentration of Tadalafil can be increased when it is combined with Ketoconazole.]
[N05AH03, olanzapine, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Olanzapine.]
[M02AA10, ketoprofen, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Ketoprofen.]
[L04AA24, abatacept, The metabolism of Tadalafil can be increased when combined with Abatacept.]
[C01CA22, arbutamine, Arbutamine may decrease the antihypertensive activities of Tadalafil.]
[N04BC09, rotigotine, Rotigotine may decrease the antihypertensive activities of Tadalafil.]
[M01AE11, tiaprofenic acid, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Tiaprofenic acid.]
[C07AG01, labetalol, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Labetalol.]
[N04BB01, amantadine, Tadalafil may decrease the excretion rate of Amantadine which could result in a higher serum level.]
[C02AA05, deserpidine, Tadalafil may increase the hypotensive activities of Deserpidine.]
[A06AX03, lubiprostone, Tadalafil may decrease the excretion rate of Lubiprostone which could result in a higher serum level.]
[C03CC01, ethacrynic acid, Etacrynic acid may increase the excretion rate of Tadalafil which could result in a lower serum level and potentially a reduction in efficacy.]
[G03AD01, levonorgestrel, The metabolism of Tadalafil can be decreased when combined with Levonorgestrel.]
[N04BA01, levodopa, Levodopa may increase the hypotensive activities of Tadalafil.]
[S02DA01, lidocaine, The metabolism of Tadalafil can be decreased when combined with Lidocaine.]
[S01AA21, amikacin, Tadalafil may decrease the excretion rate of Amikacin which could result in a higher serum level.]
[N06BA13, armodafinil, The metabolism of Tadalafil can be increased when combined with Armodafinil.]
[C03DB01, amiloride, Amiloride may increase the excretion rate of Tadalafil which could result in a lower serum level and potentially a reduction in efficacy.]
[N02CA07, lisuride, Lisuride may decrease the antihypertensive activities of Tadalafil.]
[N06AA07, lofepramine, Lofepramine may decrease the antihypertensive activities of Tadalafil.]
[N05BA06, lorazepam, Lorazepam may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[C10AA02, lovastatin, The metabolism of Tadalafil can be decreased when combined with Lovastatin.]
[L01EG01, temsirolimus, The metabolism of Temsirolimus can be decreased when combined with Tadalafil.]
[B05XA11, magnesium chloride, Tadalafil may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.]
[G04BX01, magnesium hydroxide, Tadalafil may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.]
[L01BA05, pralatrexate, Tadalafil may decrease the excretion rate of Pralatrexate which could result in a higher serum level.]
[L01EA03, nilotinib, The serum concentration of Tadalafil can be increased when it is combined with Nilotinib.]
[V04CX04, mannitol, Mannitol may increase the excretion rate of Tadalafil which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AA21, maprotiline, Tadalafil may decrease the excretion rate of Maprotiline which could result in a higher serum level.]
[C02BB01, mecamylamine, Mecamylamine may increase the hypotensive activities of Tadalafil.]
[M02AA18, meclofenamic acid, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Meclofenamic acid.]
[C03BA05, mefruside, Mefruside may increase the excretion rate of Tadalafil which could result in a lower serum level and potentially a reduction in efficacy.]
[N06DX01, memantine, Tadalafil may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N02AB02, meperidine, Meperidine may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[C01CA11, mephentermine, Mephentermine may decrease the antihypertensive activities of Tadalafil.]
[N01BB03, mepivacaine, Tadalafil may decrease the excretion rate of Mepivacaine which could result in a higher serum level.]
[G04BX16, tiopronin, Tadalafil may decrease the excretion rate of Tiopronin which could result in a higher serum level.]
[C03BC01, mersalyl, Mersalyl may increase the excretion rate of Tadalafil which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AX13, paliperidone, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Paliperidone.]
[C01CA09, metaraminol, Metaraminol may decrease the antihypertensive activities of Tadalafil.]
[A10BA02, metformin, Metformin may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[N07BC02, methadone, Methadone may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[N06BA03, methamphetamine, Metamfetamine may decrease the antihypertensive activities of Tadalafil.]
[J05AF05, lamivudine, Lamivudine may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[S01EC05, methazolamide, Methazolamide may increase the excretion rate of Tadalafil which could result in a lower serum level and potentially a reduction in efficacy.]
[G02CB05, metergoline, Metergoline may decrease the antihypertensive activities of Tadalafil.]
[H03BB02, methimazole, The serum concentration of Tadalafil can be increased when it is combined with Methimazole.]
[L01BA04, pemetrexed, Tadalafil may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[A11HA02, pyridoxine, Pyridoxine may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[L04AX03, methotrexate, Methotrexate may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[N05AA02, methotrimeprazine, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Methotrimeprazine.]
[C01CA10, methoxamine, Methoxamine may decrease the antihypertensive activities of Tadalafil.]
[D05BA02, methoxsalen, Methoxsalen may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[N02BG09, methoxyflurane, Methoxyflurane may decrease the antihypertensive activities of Tadalafil.]
[C03AA08, methyclothiazide, The therapeutic efficacy of Tadalafil can be increased when used in combination with Methyclothiazide.]
[C02AB01, methyldopa, Tadalafil may increase the hypotensive activities of Methyldopa.]
[V04CG05, methylene blue, Methylene blue may increase the hypotensive activities of Tadalafil.]
[G02AB01, methylergonovine, Methylergometrine may decrease the antihypertensive activities of Tadalafil.]
[N06BA04, methylphenidate, Methylphenidate may decrease the antihypertensive activities of Tadalafil.]
[G03EK01, methyltestosterone, Tadalafil may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.]
[N02CA04, methysergide, Methysergide may decrease the antihypertensive activities of Tadalafil.]
[A03FA01, metoclopramide, Tadalafil may decrease the excretion rate of Metoclopramide which could result in a higher serum level.]
[C03BA08, metolazone, Metolazone may increase the excretion rate of Tadalafil which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB02, metoprolol, Metoprolol may increase the hypotensive activities of Tadalafil.]
[P01AB01, metronidazole, The metabolism of Metronidazole can be decreased when combined with Tadalafil.]
[V04CD01, metyrapone, Tadalafil may decrease the excretion rate of Metyrapone which could result in a higher serum level.]
[N06AX03, mianserin, Mianserin may decrease the antihypertensive activities of Tadalafil.]
[S02AA13, miconazole, The metabolism of Tadalafil can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Aminophenazone.]
[N05CD08, midazolam, Midazolam may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[C01CA17, midodrine, Midodrine may decrease the antihypertensive activities of Tadalafil.]
[G03XB01, mifepristone, The metabolism of Mifepristone can be decreased when combined with Tadalafil.]
[J05AH01, zanamivir, Zanamivir may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[C09CA03, valsartan, Valsartan may increase the hypotensive activities of Tadalafil.]
[D11AX01, minoxidil, Minoxidil may increase the hypotensive activities of Tadalafil.]
[L01XX23, mitotane, The metabolism of Tadalafil can be increased when combined with Mitotane.]
[N06BA12, lisdexamfetamine, Lisdexamfetamine may decrease the antihypertensive activities of Tadalafil.]
[L03AC01, aldesleukin, Aldesleukin may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[C01DX12, molsidomine, Molsidomine may increase the hypotensive activities of Tadalafil.]
[C01BD01, amiodarone, The serum concentration of Tadalafil can be increased when it is combined with Amiodarone.]
[N06AA09, amitriptyline, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Amitriptyline.]
[N02AA01, morphine, Morphine may increase the hypotensive activities of Tadalafil.]
[A04AA05, palonosetron, Palonosetron may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[J01DD06, moxalactam, Latamoxef may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[L04AB05, certolizumab pegol, The metabolism of Tadalafil can be increased when combined with Certolizumab pegol.]
[G04BA01, ammonium chloride, Tadalafil may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.]
[L04AA06, mycophenolic acid, Tadalafil may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.]
[G04CA04, silodosin, The risk or severity of orthostatic hypotension and dizziness can be increased when Tadalafil is combined with Silodosin.]
[N06AA17, amoxapine, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Amoxapine.]
[N03AB05, fosphenytoin, The metabolism of Tadalafil can be increased when combined with Fosphenytoin.]
[C07AA12, nadolol, Tadalafil may increase the hypotensive activities of Nadolol.]
[J01CA04, amoxicillin, Tadalafil may decrease the excretion rate of Amoxicillin which could result in a higher serum level.]
[N04BC04, ropinirole, Ropinirole may increase the hypotensive activities of Tadalafil.]
[V03AB15, naloxone, The serum concentration of Tadalafil can be increased when it is combined with Naloxone.]
[L04AC03, anakinra, The metabolism of Tadalafil can be increased when combined with Anakinra.]
[S01GA01, naphazoline, Naphazoline may decrease the antihypertensive activities of Tadalafil.]
[N06BA01, amphetamine, Amphetamine may decrease the antihypertensive activities of Tadalafil.]
[M02AA12, naproxen, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Naproxen.]
[A10BG01, troglitazone, The metabolism of Tadalafil can be decreased when combined with Troglitazone.]
[N06AX21, duloxetine, Duloxetine may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[N04BX01, tolcapone, Tolcapone may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[L01CD02, docetaxel, The metabolism of Docetaxel can be decreased when combined with Tadalafil.]
[S03AA01, neomycin, Tadalafil may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N01AH06, remifentanil, Remifentanil may decrease the antihypertensive activities of Tadalafil.]
[C01CX08, levosimendan, Levosimendan may increase the hypotensive activities of Tadalafil.]
[B01AC17, tirofiban, Tirofiban may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[N05AX14, iloperidone, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Iloperidone.]
[J02AA01, amphotericin B, Amphotericin B may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[S01AA19, ampicillin, Ampicillin may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[L03AX16, plerixafor, Tadalafil may decrease the excretion rate of Plerixafor which could result in a higher serum level.]
[S01AA23, netilmicin, Tadalafil may decrease the excretion rate of Netilmicin which could result in a higher serum level.]
[N06AX23, desvenlafaxine, The metabolism of Tadalafil can be decreased when combined with Desvenlafaxine.]
[C09CA07, telmisartan, Tadalafil may increase the hypotensive activities of Telmisartan.]
[J05AB11, valacyclovir, Valaciclovir may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[C01CE01, inamrinone, Tadalafil may decrease the excretion rate of Amrinone which could result in a higher serum level.]
[N06AF02, nialamide, Nialamide may increase the hypotensive activities of Tadalafil.]
[C08CA04, nicardipine, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Nicardipine.]
[C04AE02, nicergoline, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Nicergoline.]
[C08CA05, nifedipine, The risk or severity of hypotension can be increased when Tadalafil is combined with Nifedipine.]
[M02AA17, niflumic acid, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Niflumic acid.]
[V03AB22, amyl nitrite, The risk or severity of hypotension can be increased when Tadalafil is combined with Amyl Nitrite.]
[C08CA06, nimodipine, Nimodipine may increase the hypotensive activities of Tadalafil.]
[C08CA07, nisoldipine, Nisoldipine may increase the hypotensive activities of Tadalafil.]
[C08CA08, nitrendipine, Tadalafil may increase the hypotensive activities of Nitrendipine.]
[R07AX01, nitric oxide, Nitric Oxide may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[J01XE01, nitrofurantoin, Nitrofurantoin may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[N05CF03, zaleplon, Tadalafil may decrease the excretion rate of Zaleplon which could result in a higher serum level.]
[N04BC05, pramipexole, Pramipexole may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[C02DD01, nitroprusside, Nitroprusside may increase the hypotensive activities of Tadalafil.]
[N01AX13, nitrous oxide, Nitrous oxide may decrease the antihypertensive activities of Tadalafil.]
[C01CA03, norepinephrine, Norepinephrine may decrease the antihypertensive activities of Tadalafil.]
[G03DC02, norethindrone, The metabolism of Tadalafil can be decreased when combined with Norethisterone.]
[C02KX01, bosentan, Bosentan may increase the hypotensive activities of Tadalafil.]
[N06AA10, nortriptyline, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Nortriptyline.]
[A16AX07, sapropterin, Sapropterin may increase the hypotensive activities of Tadalafil.]
[G02CA02, nylidrin, Nylidrin may decrease the antihypertensive activities of Tadalafil.]
[L04AC04, rilonacept, The metabolism of Tadalafil can be increased when combined with Rilonacept.]
[N06AA05, opipramol, Opipramol may decrease the antihypertensive activities of Tadalafil.]
[N02AA02, opium, Tadalafil may decrease the excretion rate of Opium which could result in a higher serum level.]
[R03CB03, metaproterenol, Orciprenaline may decrease the antihypertensive activities of Tadalafil.]
[G04CA02, tamsulosin, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Tamsulosin.]
[J01CF04, oxacillin, Oxacillin may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[N05BA04, oxazepam, Tadalafil may decrease the excretion rate of Oxazepam which could result in a higher serum level.]
[C07AA02, oxprenolol, Tadalafil may increase the hypotensive activities of Oxprenolol.]
[N02AA05, oxycodone, The metabolism of Tadalafil can be decreased when combined with Oxycodone.]
[C01DX03, oxyfedrine, Oxyfedrine may decrease the antihypertensive activities of Tadalafil.]
[S01GA04, oxymetazoline, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Oxymetazoline.]
[S01BC02, oxyphenbutazone, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Oxyphenbutazone.]
[N05AH05, asenapine, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Asenapine.]
[J04AB30, capreomycin, Tadalafil may decrease the excretion rate of Capreomycin which could result in a higher serum level.]
[G04BE02, papaverine, Papaverine may increase the hypotensive activities of Tadalafil.]
[H02AB05, paramethasone, The metabolism of Tadalafil can be increased when combined with Paramethasone.]
[C02KC01, pargyline, Pargyline may increase the hypotensive activities of Tadalafil.]
[A07AA06, paromomycin, Paromomycin may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[G04BD11, fesoterodine, Tadalafil may decrease the excretion rate of Fesoterodine which could result in a higher serum level.]
[C07AA23, penbutolol, Tadalafil may increase the hypotensive activities of Penbutolol.]
[J01CE09, penicillin G procaine, Tadalafil may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.]
[N05CA01, pentobarbital, The metabolism of Tadalafil can be increased when combined with Pentobarbital.]
[L01XX08, pentostatin, Tadalafil may decrease the excretion rate of Pentostatin which could result in a higher serum level.]
[C04AD03, pentoxifylline, Pentoxifylline may increase the hypotensive activities of Tadalafil.]
[N04BC02, pergolide, Pergolide may decrease the antihypertensive activities of Tadalafil.]
[G04BX06, phenazopyridine, Phenazopyridine may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[N06AF03, phenelzine, Phenelzine may increase the hypotensive activities of Tadalafil.]
[N03AA02, phenobarbital, The metabolism of Tadalafil can be increased when combined with Phenobarbital.]
[C04AX02, phenoxybenzamine, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Phenoxybenzamine.]
[A08AA01, phentermine, Phentermine may decrease the antihypertensive activities of Tadalafil.]
[V03AB36, phentolamine, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Phentolamine.]
[M02AA01, phenylbutazone, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Phenylbutazone.]
[S01GA05, phenylephrine, The risk or severity of hypertension can be decreased when Tadalafil is combined with Phenylephrine.]
[R01BA01, phenylpropanolamine, Phenylpropanolamine may decrease the antihypertensive activities of Tadalafil.]
[N03AB02, phenytoin, The metabolism of Tadalafil can be increased when combined with Phenytoin.]
[L04AB06, golimumab, The metabolism of Tadalafil can be increased when combined with Golimumab.]
[S01AE05, levofloxacin, Tadalafil may decrease the excretion rate of Levofloxacin which could result in a higher serum level.]
[B02BA01, vitamin K1, Tadalafil may decrease the excretion rate of Phylloquinone which could result in a higher serum level.]
[J05AB12, cidofovir, Cidofovir may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[C08CX01, mibefradil, The metabolism of Tadalafil can be decreased when combined with Mibefradil.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Tadalafil.]
[C07AA03, pindolol, Tadalafil may increase the hypotensive activities of Pindolol.]
[C10AA05, atorvastatin, The metabolism of Atorvastatin can be decreased when combined with Tadalafil.]
[J01CA12, piperacillin, Piperacillin may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[J05AE01, saquinavir, The serum concentration of Tadalafil can be increased when it is combined with Saquinavir.]
[N06BX03, piracetam, Tadalafil may decrease the excretion rate of Piracetam which could result in a higher serum level.]
[C09CA02, eprosartan, Tadalafil may increase the hypotensive activities of Eprosartan.]
[S01BC06, piroxicam, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Piroxicam.]
[J01DD16, cefditoren, Cefditoren may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[N02CX01, pizotyline, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Pizotifen.]
[J05AG02, delavirdine, The serum concentration of Tadalafil can be increased when it is combined with Delavirdine.]
[C09CA04, irbesartan, Tadalafil may increase the hypotensive activities of Irbesartan.]
[A10BG02, rosiglitazone, Rosiglitazone may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[L04AC08, canakinumab, The metabolism of Tadalafil can be increased when combined with Canakinumab.]
[C03AA05, polythiazide, The therapeutic efficacy of Tadalafil can be increased when used in combination with Polythiazide.]
[J05AE03, ritonavir, The serum concentration of Tadalafil can be increased when it is combined with Ritonavir.]
[A10BH03, saxagliptin, Tadalafil may decrease the excretion rate of Saxagliptin which could result in a higher serum level.]
[B05XA01, potassium chloride, Potassium chloride may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[C07AB01, practolol, Tadalafil may increase the hypotensive activities of Practolol.]
[P02BA01, praziquantel, The metabolism of Praziquantel can be decreased when combined with Tadalafil.]
[C02CA01, prazosin, The risk or severity of hypotension can be increased when Prazosin is combined with Tadalafil.]
[H02AB07, prednisone, Prednisone may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[P01BA03, primaquine, The metabolism of Tadalafil can be decreased when combined with Primaquine.]
[N03AA03, primidone, The metabolism of Tadalafil can be increased when combined with Primidone.]
[M04AB01, probenecid, Tadalafil may decrease the excretion rate of Probenecid which could result in a higher serum level.]
[C01BA02, procainamide, Tadalafil may decrease the excretion rate of Procainamide which could result in a higher serum level.]
[S01HA05, procaine, Procaine may increase the hypotensive activities of Tadalafil.]
[L01XB01, procarbazine, Procarbazine may increase the hypotensive activities of Tadalafil.]
[C10AB05, fenofibrate, Tadalafil may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[G03DA04, progesterone, The metabolism of Tadalafil can be decreased when combined with Progesterone.]
[N05AA03, promazine, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Promazine.]
[R06AD02, promethazine, Tadalafil may decrease the excretion rate of Promethazine which could result in a higher serum level.]
[C01BC03, propafenone, Propafenone may decrease the antihypertensive activities of Tadalafil.]
[A03AB05, propantheline, Propantheline may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[N05AC01, periciazine, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Periciazine.]
[N05CM06, propiomazine, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Propiomazine.]
[L01XH02, romidepsin, The metabolism of Romidepsin can be decreased when combined with Tadalafil.]
[N01AX10, propofol, Propofol may decrease the antihypertensive activities of Tadalafil.]
[C07AA05, propranolol, Propranolol may increase the hypotensive activities of Tadalafil.]
[N02CC04, rizatriptan, Rizatriptan may decrease the antihypertensive activities of Tadalafil.]
[B01AC09, epoprostenol, Epoprostenol may increase the hypotensive activities of Tadalafil.]
[N06AA11, protriptyline, Protriptyline may decrease the antihypertensive activities of Tadalafil.]
[R01BA02, pseudoephedrine, Pseudoephedrine may decrease the antihypertensive activities of Tadalafil.]
[N05AX12, aripiprazole, The risk or severity of hypotension can be increased when Aripiprazole is combined with Tadalafil.]
[N07XX07, dalfampridine, Tadalafil may decrease the excretion rate of Dalfampridine which could result in a higher serum level.]
[P02CC01, pyrantel, Tadalafil may decrease the excretion rate of Pyrantel which could result in a higher serum level.]
[J04AK01, pyrazinamide, Pyrazinamide may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[P01AX05, quinacrine, The metabolism of Quinacrine can be decreased when combined with Tadalafil.]
[C01BA01, quinidine, Tadalafil may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[P01BC01, quinine, Quinine may increase the hypotensive activities of Tadalafil.]
[A02BA02, ranitidine, Tadalafil may decrease the excretion rate of Ranitidine which could result in a higher serum level.]
[C02AA01, rescinnamine, Rescinnamine may decrease the antihypertensive activities of Tadalafil.]
[C02AA02, reserpine, The metabolism of Tadalafil can be increased when combined with Reserpine.]
[J05AP01, ribavirin, Ribavirin may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[J04AB02, rifampin, The metabolism of Tadalafil can be increased when combined with Rifampicin.]
[R03AC05, rimiterol, Rimiterol may decrease the antihypertensive activities of Tadalafil.]
[G02CA01, ritodrine, Ritodrine may decrease the antihypertensive activities of Tadalafil.]
[N02BA05, salicylamide, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Salicylamide.]
[A07EC01, sulfasalazine, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Sulfasalazine.]
[S01BC08, salicylic acid, The therapeutic efficacy of Tadalafil can be decreased when used in combination with Salicylic acid.]
[N05CA06, secobarbital, Secobarbital may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[N04BD01, selegiline, Selegiline may increase the hypotensive activities of Tadalafil.]
[L01FA03, obinutuzumab, Tadalafil may increase the hypotensive activities of Obinutuzumab.]
[J01GB08, sisomicin, Tadalafil may decrease the excretion rate of Sisomicin which could result in a higher serum level.]
[A12CD01, sodium fluoride, Tadalafil may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.]
[V04CC01, sorbitol, Tadalafil may decrease the excretion rate of Sorbitol which could result in a higher serum level.]
[C07AA07, sotalol, Sotalol may increase the hypotensive activities of Tadalafil.]
[L01CD04, cabazitaxel, The metabolism of Cabazitaxel can be decreased when combined with Tadalafil.]
[C03DA01, spironolactone, Spironolactone may increase the excretion rate of Tadalafil which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CC01, chloral hydrate, Tadalafil may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.]
[D07AB02, hydrocortisone butyrate, The metabolism of Hydrocortisone butyrate can be decreased when combined with Tadalafil.]
[C01DA14, isosorbide mononitrate, Tadalafil may increase the vasodilatory activities of Isosorbide mononitrate.]
[H02CA04, levoketoconazole, The serum concentration of Tadalafil can be increased when it is combined with Levoketoconazole.]
[D10AX03, azelaic acid, Azelaic acid may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
